Thy1.1 mice were immunized with BALB/c splenocytes (3 × 107, i.p.) and spleen and LN cells were harvested 6 – 12 weeks later to sort for CD8 TCM and TEM. (A) Sorting of CD8 memory T cell subsets. CD8 memory T cell subsets were sorted after gating on CD8+CD44highCD62Lhigh cells (CD8 TCM) and CD8+CD44highCD62Llow cells (CD8 TEM). Sorted cells were tested for purity prior to adoptive transfer. (B) Phenotype of CD8 TCM and TEM. Expression of CD69, 1B11, CD25, CD27, CD127 and CD122 on CD8 TCM and TEM is shown (representative FACS plots of 5 – 6 experiments). (C)
Ex-vivo IFNγ production by CD8 TCM and TEM. Sorted CD8 TCM and TEM were assessed for IFNγ production by intracellular cytokine staining after 5-hr ex-vivo stimulation with BALB/c splenocytes. IFNγ production within the Thy1.1+ population is shown after gating on CD8+ T cells. Naïve T cells from unimmunized Thy1.1 mice (Naïve) and unfractionated sorted CD8+ CD44high memory T cells (CD8 memory) from immunized Thy1.1 mice that contained both CD62Lhigh and CD62Llow cells were used as controls. Representative FACS plots of 4 – 5 experiments are shown. (D) Quantitation of alloreactive IFNγ+ T cells within CD8 TCM and TEM subsets after 5-hr ex-vivo stimulation with BALB/c splenocytes. Percent of IFNγ+ T cells within naïve, unfractionated CD8 memory (memory) and sorted CD8 TCM and TEM populations. Mean ± SD of 4 – 5 experiments. (E) Alloreactive IFNγ+ T cells within CD8 TCM and TEM subsets upon ex-vivo stimulation with BALB/c splenocytes over time. Percent of IFNγ+ T cells within naïve, sorted CD8 TCM and TEM populations after ex-vivo stimulation with BALB/c splenocytes at 6hrs, 12hrs and 24hrs. (F)
In-vivo cytotoxicity of alloreactive CD8 TCM and TEM subsets in wt adoptive hosts. Wt mice were treated with anti-NK1.1 (PK136, 300µg, i.p.) to deplete NK cells. 3-days later, sorted CD8 TCM (1.9 × 106) or CD8 TEM (5 × 105) containing similar numbers of BALB/c-reactive IFNγ+ T cells were transferred to wt adoptive hosts followed by injection of equal numbers of CFSE labeled H-2b (5 × 106, 2µM B6, syngeneic) and H-2d (5 × 106, 0.2µM, BALB/c, allogeneic) splenocytes on the same day. 12-hrs later, in vivo killing of target cells was measured in harvested spleen and LN cells as loss of H-2d target cells compared to loss of H-2b syngeneic cells in adoptive hosts of memory T cells (TCM or TEM) versus naïve B6 control mice (as described in Materials and Methods) (representative FACS plots of n = 3 mice/grp are shown). (G) Quantitation of in-vivo specific lysis of allogeneic cells by alloreactive CD8 TCM and TEM subsets in wt adoptive hosts. Percent of BALB/c-cell lysis in harvested spleen and LNs from wt adoptive hosts of CD8 TCM or TEM. Mean ± SD of n = 3 mice/grp. (H) Expression of chemokine and adhesion receptors on CD8 TCM and TEM. Expression of CCR7, CXCR3, CCR5, CD49d (α4-integrin), β1-integrin, α4β7 and CD11a (LFA-1) on CD8 TCM and TEM subsets shown in comparison to CD8+ CD44low naïve T cells (representative FACS plots of 3 – 4 experiments).